Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multisystem Complications in Spinal Muscular Atrophy Type III: Chronic Respiratory Failure and Intractable Epilepsy. | Cureus | 2026 | 42299170 | PubTator, text mining | PubMed |
| Elucidation of the molecular binding mechanism of an anticancer thiolato-bridged manganese(I) carbonyl complex with apotransferrin: Thermodynamic and structural insights. | Biochem Biophys Res Commun | 2026 | 42296687 | PubTator, text mining | PubMed |
| A Gene, A Breakthrough, A Challenge: Lessons From the History of Spinal Muscular Atrophy. | J Child Neurol | 2026 | 42286918 | PubTator, text mining | PubMed |
| The SMN locus in the T2T era: Structure, gene conversion, and clinical implications. | Trends Genet | 2026 | 42276860 | PubTator, text mining | PubMed |
| Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan. | Ann Clin Transl Neurol | 2026 | 42265796 | PubTator, text mining | PubMed |
| Characterizing SMN1 hybrid and deletion alleles using large-scale SNP array-based SMA carrier screening. | BMC Med Genomics | 2026 | 42251298 | PubTator, text mining | PubMed |
| Advancements in Prenatal Diagnosis and Potential Fetal Therapies for Spinal Muscular Atrophy. | Clin Ther | 2026 | 42203536 | PubTator, text mining | PubMed |
| An approach for the systematic profiling of drug-induced remodeling of RNA-RBP (RNA-binding protein) interactions. | RSC Adv | 2026 | 42170088 | PubTator, text mining | PubMed |
| Enhanced splicing modulation by NMA-modified antisense oligonucleotides. | Nucleic Acids Res | 2026 | 42165132 | PubTator, text mining | PubMed |
| The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single SMN2 copy: an international retrospective observational study. | EClinicalMedicine | 2026 | 42163975 | PubTator, text mining | PubMed |
| Multimodal characterisation of the SMN locus in SMA: copy number quantification and hybrid gene identification. | NPJ Genom Med | 2026 | 42162012 | PubTator, text mining | PubMed |
| Nusinersen: the antisense oligonucleotide at the forefront of spinal muscular atrophy treatment. | RNA Biol | 2026 | 42149739 | PubTator, text mining | PubMed |
| Elective preterm birth for earlier spinal muscular atrophy treatment. | Mol Ther Adv | 2026 | 42137283 | PubTator, text mining | PubMed |
| [Newborn screening and early disease-modifying therapy for spinal muscular atrophy in the Foshan region]. | Zhonghua Er Ke Za Zhi | 2026 | 42135234 | PubTator, text mining | PubMed |
| Detection and characterization of SMN1 deletions in type IV spinal muscular atrophy using long-read whole-genome sequencing. | Clin Chim Acta | 2026 | 42128322 | PubTator, text mining | PubMed |
| Beyond SMN1 mutation: environmental predispositions and epigenetic contributors to phenotypic variability and disease severity in spinal muscular atrophy. | Neuroscience | 2026 | 42105903 | PubTator, text mining | PubMed |
| Exploring the phenotypic and genotypic spectrum of spinal muscular atrophy in Bangladeshi children. | BMC Neurol | 2026 | 42104248 | PubTator, text mining | PubMed |
| [Spinal muscular atrophy: Clinical and genetic aspects, and therapeutic alternatives]. | Rev Med Inst Mex Seguro Soc | 2026 | 42095821 | PubTator, text mining | PubMed |
| Adherence, Persistence, and Safety of Risdiplam in Spinal Muscular Atrophy: A Population-Based Cohort Study. | Neurol Ther | 2026 | 42090081 | PubTator, text mining | PubMed |
| Hip instability and scoliosis in children with spinal muscular atrophy: a single center retrospective study in the United Arab Emirates. | Front Pediatr | 2026 | 42088756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=3